SAN FRANCISCO (MarketWatch) - In the latest chapter of the saga on who will end up buying Guidant Corp., Boston Scientific Corp. said Sunday it has formalized its offer to acquire the medical device maker for about $25 billion.
http://c.moreover.com/click/here.pl?r451369580
http://c.moreover.com/click/here.pl?r451369580